We found that TGF‐β1 blockade also decreased the mRNA expression of non‐canonical signaling pathways, including RhoA, MAPK, Akt and NFκB, suggesting that both canonical and non‐canonical signaling pathways regulate responses to increased TGF‐β1 expression in lymphedema. The gene discussed is NFKB1; the disease is lymphedema.